Rx-360 An International Pharmaceutical Supply Chain Consortium

Size: px
Start display at page:

Download "Rx-360 An International Pharmaceutical Supply Chain Consortium"

Transcription

1 Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011

2 Rx-360 Members (Continuously updated list at Manufacturers (24) Abbott Amgen Amylin AstraZeneca Baxter Bayer Biogen Idec Boehringer Ingelheim BMS Cephalon Eli Lilly Forest Laboratories Roche/Genentech GSK Hospira Johnson & Johnson Mylan Inc. Merck & Co. Novartis Pfizer Sanofi-Aventis Takeda Teva Watson Suppliers (24) AMPAC Fine Chemicals LLC Arch Pharmalab (USA) Inc. Avantor Performance Materials, Inc. BASF Doe & Ingalls DSM Nutritional Products Ltd Fagron GE Healthcare Hikal Hovione ISP Labochim LifeConEx Life Technologies Corp. Merck KGaA Novozymes OSO BioPharmaceuticals Manufacturing LLC SICPA Sigma Aldrich Spectrum Chemical & Laboratory Products TempTime VWR West York Container 2

3 Rx-360 Observers (Continuously updated list at Auditors (7) PSC Biotech Corp. Regulatory Compliance Associates RMC Pharmaceutical Solutions Inc. Safis Solutions LLC SQA Services Inc. The Weaver Group, Inc. Auckerman Consulting Associations (11) APIC Bulk Pharmaceutical Task Force Clinton Health Access Initiative, Inc. Council for Responsible Nutrition European Fine Chemicals Group (EFCG) European Generic Medicines Association (EGA) IPEC Americas IPEC Europe NSD Bio Group Parenteral Drug Association (PDA) Pharmaceutical Quality Group (PQG) 3

4 Eligibility for Membership in Rx The following entities are eligible to become Members, subject to exceptions noted below: manufacturers of pharmaceutical or biotechnology finished products; suppliers of ingredients and components of pharmaceutical or biotechnology products; and suppliers of services relating to the quality or safety of the pharmaceutical or biotechnology supply chain. Exceptions: Providers of auditing services concerning the quality systems for, and quality of, pharmaceutical or biotechnology products, ingredients or components are not eligible for Rx- 360 membership. Providers of auditing services are eligible to become Observers of Rx Consultants are not eligible for Rx-360 membership. The following types of entities are eligible to become Observers of Rx-360: a governmental unit or quasi-governmental unit; a non-profit trade or professional association comprised of (a) pharmaceutical or biotechnology manufacturers, (b) suppliers of pharmaceutical/biotechnology ingredients or components, (c) suppliers of services relating to the quality or safety of the pharmaceutical or biotechnology supply chain, and/or (d) individuals employed by or whose activities relate to the pharmaceutical or biotechnology industries; and auditors of the quality systems for, and quality of, pharmaceutical or biotechnology products, ingredients or components. 4

5 How to Become a Member For Manufacturers and Suppliers: Review the Rx-360Antitrust/Anticompetitive Policy Review the Rx-360Bylaws. Sign and submit Membership Agreement to Rx-360 Secretariat For Observers Review the Rx-360Antitrust/Anticompetitive Policy Review the Rx-360Bylaws. Sign and submit Observer Agreement to Rx-360 Secretariat 5

6 By-laws and Agreements -- General Rx-360 By-laws Membership Agreement Observer Agreement Anti-trust/Anti-competitive Policy 6

7 Agreements for Participation in Audit Sharing Program Accessed through Rx-360 Database Membership Supplemental Confidentiality Agreement Between pharmaceutical manufacturer member or supplier member and Rx-360 Confidential Disclosure Agreement (CDA) Concerning Audit by Individual Rx-360 Member Between supplier and Rx-360 7

8 Agreements for Participation in Audit Sharing Program (Diagram) Pharma and Suppliers (Rx-360 Members) Suppliers (Rx-360 Members and Non-members) Membership Supplemental Confidentiality Agreement CDA for Audit by Individual Rx-360 Member Rx-360 Secretariat 8

9 Audit Sharing Concept Share reports and responses from audits conducted by individual member companies (not by Rx-360) Companies decide individually how to use information in the audit reports/responses Suppliers can exclude specific companies (i.e., competitors) from viewing the audit reports/responses Suppliers can also vet new members joining Rx-360 who have requested access to a Shared audit report 9 9

10 Benefits of Sharing Audit Reports for Sponsors and Suppliers Leveraging Information Already Available Provides a Broader Picture of Quality Culture and Performance Potential for Reducing Frequency and/or Length of Audits (Routine/Due Diligence) Identify and Pre-screen New Suppliers Promote Capabilities to Consortium Competitive Advantage and Visibility to Potential Customers 10

11 Audit Sharing Process: Overview Sponsor & Supplier agree to share audit report/responses Sponsor & Supplier Redact reports/responses Rx-360 uploads reports/responses into database (documents controlled by CDAs) 11

12 Audit Sharing Process: Detail (Scope and process described in further detail in Rx-360 SOPs) Plan to Share Audit Agree to Share Audit Report (and Responses) Redact Audit Report (and Responses) Share Audit Report (and Responses) Sponsors sign CDA Sponsors identify and contact suppliers that they will audit during the year Sponsors inform suppliers of the audit sharing program and ask them to participate Sponsors register suppliers in database Supplier reviews audit sharing information and speaks with Sponsor and/or Coordinator Supplier agrees to share audit report and responses (this can be done prior to or after the audit report is issued) Supplier signs CDA and identifies Rx-360 member companies that are allowed access to report/responses Sponsor redacts audit report and sends to supplier Supplier redacts audit report (if needed) and sends to Coordinator Coordinator uploads audit report into database 12 12

13 Rx-360 Database (1) Accessible to Rx-360 members Managed according to a Database Protocol describing, e.g., Change management (for the database) Security Disaster recovery Naming conventions Two main sections: Consortium internal documents (e.g, minutes, slides) Shared and Join Audit Program materials 13

14 Rx-360 Database (2) Shared Audit Program Materials Quality Management System (Quality Manual) Audit Reports and Responses Shared Audits Standard Operating Procedures (SOPs) Database protocol Signed Agreements Membership Suppliers 14

15 Quality Management System (QMS) Accessed through Rx-360 database Describes the Rx-360 Quality Policy Describes the Rx-360 Code of Ethics Describes policies for Developing Rx-360 procedures Governance Roles and responsibilities Audit processes Integrates and describes the Audit Sharing and Joint Audits goals and processes Describes key aspects and purpose of database Describes document management Describes and refers to forms, templates, SOPs, protocols, and agreements relevant to audit programs 15

Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency

Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:

More information

Pharma working capital leaves room for improvement

Pharma working capital leaves room for improvement October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.

More information

In the largest and perhaps the most ambitious collaborative

In the largest and perhaps the most ambitious collaborative FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated

More information

Evolving tactical video production- Creative Studios

Evolving tactical video production- Creative Studios WHITEPAPER JUNE 2014 www.beroe-inc.com Evolving tactical video production- Creative Studios Abstract / Business Case 1. Introduction:This whitepaper help pharma clients who allocate lower budgets to their

More information

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors

More information

Pharma working capital performance highly variable

Pharma working capital performance highly variable April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the

More information

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality 6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors

More information

Multiple Sclerosis Treatments: World Market Outlook to 2011

Multiple Sclerosis Treatments: World Market Outlook to 2011 Brochure More information from http://www.researchandmarkets.com/reports/2860814/ Multiple Sclerosis Treatments: World Market Outlook to 2011 Description: Multiple sclerosis (MS) is a chronic demyelinating

More information

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017

More information

ehealthinsight Series: Online Patient Recruitment Strategies

ehealthinsight Series: Online Patient Recruitment Strategies A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient

More information

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for

More information

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for

More information

Biotechnology in North Carolina

Biotechnology in North Carolina Biotechnology in North Carolina UNC-DoD Roundtable Bio-supported Products and Systems for the National Defense September 16, 2004 Kenneth R. Tindall, Ph.D. Sr. V. P. for Science and Business Development

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

1) SCOPE OF THE PROGRAM

1) SCOPE OF THE PROGRAM CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany

More information

THE GABOR DANIELFY SCHOLARSHIP FOR HEALTHCARE COMPLIANCE & ETHICS

THE GABOR DANIELFY SCHOLARSHIP FOR HEALTHCARE COMPLIANCE & ETHICS THE GABOR DANIELFY SCHOLARSHIP FOR HEALTHCARE COMPLIANCE & ETHICS I. Mission: Seton Hall Law School, Sciences Po, and ETHICS - the International Society of Healthcare Ethics and Compliance Professionals,

More information

The Gold Standard for Processing and Packaging

The Gold Standard for Processing and Packaging PACK EXPO Las Vegas Exhibitor Prospectus The Gold Standard for Processing and Packaging 2 O YEARS co-located with: packexpolasvegas.com/exhibit2015 A Reliable Source of Excellence When you exhibit at PACK

More information

How companies leverage quality and quality certifications to achieve competitive advantage

How companies leverage quality and quality certifications to achieve competitive advantage How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for

More information

INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS

INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS I. INTRODUCTION The International Pharmaceutical Privacy Consortium (IPPC)

More information

Sage ERP I White Paper

Sage ERP I White Paper The Premier Provider of Effective Business Software Solutions National Presence, Local Touch 1.800.4.BLYTHE www.blytheco.com I White Paper Proactive Regulatory Compliance for Biopharmaceutical Global Competitiveness

More information

Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor

Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor Steven Snapinn SCT/QSPI/FDA Workshop Innovations in the Science

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

GSK Public policy positions

GSK Public policy positions Product Donations The Issue As a global healthcare company operating in countries throughout the world, GSK recognises a responsibility to make product donations in the form of ongoing humanitarian assistance

More information

Manufacturer of drug substance

Manufacturer of drug substance Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin

More information

Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry

Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry A Glance at the Pharmaceutical Industry The pharmaceutical industry is

More information

To know more about Pharmacovigilance and Clinical Trials Data Management

To know more about Pharmacovigilance and Clinical Trials Data Management To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding

More information

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com

More information

Annual Press Conference 2012. Business Year 2011

Annual Press Conference 2012. Business Year 2011 Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation

More information

Rx-360 Supply Chain Security White Paper: Incident Management

Rx-360 Supply Chain Security White Paper: Incident Management Rx-360 Supply Chain Security White Paper: Incident Management 1 Contents Background... 3 Scope... 3 Definitions... 4 Introduction... 5 Discovery & Investigation... 5 Incident Management... 6 Lessons Learned...

More information

Global Multiple Sclerosis Market: Trends and Opportunities (2013-18)

Global Multiple Sclerosis Market: Trends and Opportunities (2013-18) Global Multiple Sclerosis Market: Trends and Opportunities (2013-18) Scope of the Report The report titled Global Multiple Sclerosis Market: Trends & Opportunities (2013-18) provides an insight into the

More information

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality

Pharmaceutical Quality Systems (ICH Q10) Conference. Business Case for Quality Pharmaceutical Quality Systems (ICH Q10) Conference Business Case for Quality Jeffrey Macher, PhD Associate Professor McDonough School of Business Georgetown University Presentation Agenda Business Case

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

Pharmaceutical Distribution in the US: Current and Future Perspectives

Pharmaceutical Distribution in the US: Current and Future Perspectives Pharmaceutical Distribution in the US: Current and Future Perspectives Publication date: July 2009 Number of pages: 83 Author: Dr Faiz Kermani Pricing: 1,495 (PDF) / 1,550 (print) "In the US, the pharmaceutical

More information

PHARMACEUTICAL INDUSTRY PROFILE

PHARMACEUTICAL INDUSTRY PROFILE PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,

More information

Tuas Biomedical Park

Tuas Biomedical Park Tuas Biomedical Park About Tuas Biomedical Park Tuas Biomedical Park symbolises JTC s commitment in developing a world-class manufacturing hub for the biomedical industry. The park is located in Tuas View,

More information

GMP Pharma BV. Netherlands

GMP Pharma BV. Netherlands GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization

More information

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage

More information

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association

More information

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This

More information

TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet

TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating

More information

Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009

Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009 Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009 2009 SAFE-BioPharma Association Overview Conducting Business in the Electronic World

More information

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and

More information

INCENTIVE COMPENSATION CONFERENCE

INCENTIVE COMPENSATION CONFERENCE Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed

More information

Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration

Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011

More information

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams

More information

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Commercial Insight Osteoarthritis and Rheumatoid Arthritis A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and

More information

CALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com

CALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com CALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com ENGINEERING A PIVOTAL ROLE IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES

More information

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design Copyright 2007 Scott M. Fishman, MD CME Activity Copyright 2009 The University of Wisconsin Board of Regents Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen

More information

The Role Of Industry in the Australian Clinical Trials Sector

The Role Of Industry in the Australian Clinical Trials Sector Mitch Kirkman, Development QA Manager Australian Clinical Trials Alliance Symposium 09 October 2015 CORP0270 September 2015 Global Clinical Development Local Clinical Trials Australian Medical Research

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

Metastatic Breast Cancer - Pipeline Review, Q1 2011

Metastatic Breast Cancer - Pipeline Review, Q1 2011 Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

Pharmaceutical Marketing Disclosures

Pharmaceutical Marketing Disclosures Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

APV/IPEC Europe Excipient Conference 2014

APV/IPEC Europe Excipient Conference 2014 APV/IPEC Europe Excipient Conference 2014 An update on regulatory and application developments 23 to 24 September 2014 Düsseldorf, Germany Course No. 3128 Marketing Düsseldorf Target Group This conference

More information

Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön

Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön Dr. Darvas Ferenc Dr. Remzsı Tibor ThalesNano Zrt. (Budapest), ThalesNano LLC (Princeton, NJ, USA) Main Tech

More information

EU Clinical Trials Register

EU Clinical Trials Register EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 euclinicaltrials@abbott.com

More information

Health Care Job Information Sheet #20. Clinical Research

Health Care Job Information Sheet #20. Clinical Research Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour

More information

Digital Leaders Deal With a Range of Organizational Challenges

Digital Leaders Deal With a Range of Organizational Challenges May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij

More information

KEEPING CLINICAL TRIALS IN AUSTRALIA

KEEPING CLINICAL TRIALS IN AUSTRALIA OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought

More information

Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions

Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Philip S. Brewster Brewster Law Firm LLC July 29, 2014 Schering Charitable

More information

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit 2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China

More information

Accelerating Drug & Clinical Trial Approvals in China & East Asia

Accelerating Drug & Clinical Trial Approvals in China & East Asia 25 28 March 2014 The Westin Beijing Chaoyang, Accelerating Drug & Clinical Trial Approvals in & East Asia What s New in 2014? Key Regulatory Update from the National Institute for Food & Drug Control,

More information

Global Pharmaceuticals Marketing Channel Reference EDITION

Global Pharmaceuticals Marketing Channel Reference EDITION Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry

More information

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries

More information

Pipeline, timeline, deadline

Pipeline, timeline, deadline Pipeline, timeline, deadline Improve your bottom line Life Sciences Building Management Solutions Put your buildings to work for you Keep your product pipeline flowing We ll show you how You re up against

More information

Main Conference Agenda

Main Conference Agenda Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental

More information

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight

More information

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services.

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services. CONCEPT HEIDELBERG Pharmaceutical Quality Training. Conferences. Services. About Us Helping you to Comply with GMP Since our foundation on 1 April 1978, CONCEPT HEIDELBERG has been concentrating on providing

More information

Roots Analysis Pvt. Ltd.

Roots Analysis Pvt. Ltd. Roots Analysis Pvt. Ltd. http://www.marketresearch.com/rootsanalysispvt.ltd. -v3981/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am

More information

Black Mountain Consulting Group. Not just Knowledge..Know-How

Black Mountain Consulting Group. Not just Knowledge..Know-How Black Mountain Consulting Group Not just Knowledge..Know-How BMCG in a Nutshell. A collaborative of more than 45 Pharmaceutical Industry experts, each with more than 10 years of success in their well defined

More information

Medical Writing Takes Off in India

Medical Writing Takes Off in India Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com

More information

van den Besselaar Mobile Phone no. : +31(0) 653796401 E-mail: leo.besselaar@lbqconsultancy.nl

van den Besselaar Mobile Phone no. : +31(0) 653796401 E-mail: leo.besselaar@lbqconsultancy.nl Resume/CV Leo van den Besselaar Personal Details Title Ing. Male Surname or family name van den Besselaar First or given name Leo (Leonardus Adrianus Maria) Nationality Dutch Date of Birth June 12, 1963

More information

The United States False Claims Act Qui Tam Whistleblower Law

The United States False Claims Act Qui Tam Whistleblower Law The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com

More information

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation

More information

How To Schedule A Lab

How To Schedule A Lab Online Exclusive from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2012, Vol. 32 No. 5 www.pharmaceuticalengineering.org Copyright ISPE 2012 This article presents the various

More information

Pharmaceutical industry

Pharmaceutical industry 8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and

More information

Peter Erickson. C2 Healthcare CREATIVE DIRECTOR/COPY/CONTENT. Chicago. Creative Director/Senior Copywriter/Content Strategist

Peter Erickson. C2 Healthcare CREATIVE DIRECTOR/COPY/CONTENT. Chicago. Creative Director/Senior Copywriter/Content Strategist Peter Erickson CREATIVE DIRECTOR/COPY/CONTENT Chicago Leading, inspiring, innovating. bookhouse@sbcglobal.net 630.253.5199 mobile Challenges drive most of us creative professionals. As a creative director,

More information

Resource Scheduling in QC Laboratories

Resource Scheduling in QC Laboratories Reprinted from PHARMACEUTICAL ENGINEERING The Official Technical Magazine of ISPE November/December 2012, Vol 32, No 6 Copyright ISPE 2012 www.pharmaceuticalengineering.org quality systems in QC Laboratories

More information

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Amgen GLOBAL CORPORATE COMPLIANCE POLICY 1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

New Jersey Bio-Pharmaceutical Life Sciences Landscape

New Jersey Bio-Pharmaceutical Life Sciences Landscape New Jersey Bio-Pharmaceutical Life Sciences Landscape Prepared By: John Ehret Labor Market Analyst New Jersey Department of Labor & Workforce Development Division of Labor Market & Demographic Research

More information

Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)

Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) Patterns and predictors of suicides in the U.S. Army: An introduction to the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) Ronald C. Kessler, Ph.D. Harvard Medical School March

More information

from PKI to Identity Assurance

from PKI to Identity Assurance from PKI to Identity Assurance Richard Trevorah Technical Manager tscheme Ltd Tel: +44 (0)7818 094728 richard.trevorah@tscheme.org What is tscheme? tscheme is a not-for-profit membership organisation chartered

More information

VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY

VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises

More information

Biopharmaceutical Raw Materials throughout the Product Lifecycle

Biopharmaceutical Raw Materials throughout the Product Lifecycle February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing

More information

The Board reviews risks to the Company s business plan at its scheduled meetings.

The Board reviews risks to the Company s business plan at its scheduled meetings. Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board

More information

Roopa Ramamoorthi PhD, PMP, Associate Director, Partnering and Scientific Affairs

Roopa Ramamoorthi PhD, PMP, Associate Director, Partnering and Scientific Affairs Roopa Ramamoorthi PhD, PMP, Associate Director, Partnering and Scientific Affairs BIO Ventures for Global Health Sharing Innovation in the Fight Against Neglected Tropical Diseases World Intellectual Property

More information

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management

PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: crtraining@avesthagen.com PG Diploma In Clinical Research,

More information

Medical Communication Companies and Industry Grants

Medical Communication Companies and Industry Grants Research Brief Report Communication Companies and Industry Grants Sheila M. Rothman, PhD; Karen F. Brudney, MD; Whitney Adair, BA; David J. Rothman, PhD IMPORTANCE communication companies (MCCs) are among

More information

PROGRAM PLAN FOR THE ONTARIO MEDICATIONS RETURN PROGRAM

PROGRAM PLAN FOR THE ONTARIO MEDICATIONS RETURN PROGRAM PROGRAM PLAN FOR THE ONTARIO MEDICATIONS RETURN PROGRAM April 2013 Executive Summary Ontario Regulation 298/12 "Collection of Pharmaceuticals and Sharps - Responsibility of Producers" came into force on

More information

An integrated global healthcare company

An integrated global healthcare company An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment

More information

Services Providers. Ivan Soto

Services Providers. Ivan Soto SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed

More information

Ross Career Services. Health Care. Introduction. Health Care Overview

Ross Career Services. Health Care. Introduction. Health Care Overview Ross Career Services Career Path: Health Care Introduction Ross Career Services (RCS) created the Career Path series to assist students with the career search process. Each Career Path (online) handout

More information

Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements

Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements Thomas W. Beimers Special Counsel Faegre Baker Daniels LLP Minneapolis MN Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements The Department of Health & Human Services,

More information

Source: BIO, Factset, NASDAQ

Source: BIO, Factset, NASDAQ Inside The NBI A guide to performance drivers of the NASDAQ Biotech Index Introduction The NASDAQ Biotechnology Index (NBI) is referenced by investors, CEOs, and industry leaders around the world to take

More information

Document and Quality Management Solutions for Life Sciences

Document and Quality Management Solutions for Life Sciences Document and Quality Management Solutions for Life Sciences Company Overview Global Provider Established US and European footprint Proven Solution SharePoint based document and quality management. Solutions

More information

ABCD. Welcome to BICI. Petersburg, Virginia

ABCD. Welcome to BICI. Petersburg, Virginia Welcome to BICI Petersburg, Virginia Our Company Our Worldwide Company in Brief: - Focus on Human Pharmaceuticals and Animal Health - Founded 1885 in Ingelheim, Germany - Products marketed in some 150

More information